CDC vaccine panel holds first meeting since RFK Jr. put immunization critics in place

CDC vaccine panel holds first meeting since RFK Jr. put immunization critics in place


A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia.

Tami Chappell | Reuters

A crucial government panel of vaccine advisors will hold its first meeting Wednesday since Health and Human Services Secretary Robert F. Kennedy Jr. appointed several vaccine critics to the group. 

Earlier this month, Kennedy in a stunning step removed and replaced all members of the Advisory Committee on Immunization Practices, or ACIP, which advises the Centers for Disease Control and Prevention. The group reviews vaccine data and makes recommendations that determine who is eligible for shots and whether insurers should cover them, among other efforts.

It is unclear how Kennedy’s new members, given some of their skepticism of immunizations, will affect vaccine policy and availability in the U.S. 

During a full-day meeting Wednesday in Atlanta, the panel will evaluate data on Covid-19 vaccines and RSV shots, with a vote on recommendations for the latter. The group will convene again on Thursday to review data on shots for the flu and other diseases. 

The CDC director has to sign off on those recommendations for them to become official policy.

ACIP members are independent medical and public experts who make recommendations based on rigorous scientific review and evidence. But Kennedy’s eight new members include some well-known vaccine critics, such as Dr. Robert Malone.

Malone bills himself as having played a key role in the creation of mRNA vaccines, but has gained a large following for making baseless and disproven claims about Covid-19 shots. 

Another new member, Retsef Levi, has pushed to stop giving mRNA vaccines, falsely claiming in a post on X that they cause “serious harm including death, especially among young people.” 

The meeting on Wednesday will begin at 10 a.m. ET. 



Source

Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Health

Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Competition in […]

Read More
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
Health

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%

The “Wegovy” brand slimming syringe is sold in the Achat pharmacy in Mitte. The “Wegovy” slimming syringe has been available in Germany for a year. Jens Kalaene | Picture Alliance | Getty Images Novo Nordisk on Monday said it is ending its collaboration with Hims & Hers due to concerns about the telehealth company’s sales […]

Read More
Major U.S. health insurers say they will streamline controversial process for approving care
Health

Major U.S. health insurers say they will streamline controversial process for approving care

UnitedHealthcare signage is displayed on an office building in Phoenix, Arizona, on July 19, 2023. Patrick T. Fallon | Afp | Getty Images Health plans under major U.S. insurers said Monday they have voluntarily agreed to speed up and reduce prior authorizations – a process that is often a major pain point for patients and […]

Read More